SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Lexicon Pharmaceuticals, Inc. Initiates Phase 3 Clinical Trial of Telotristat Etiprate in Patients With Carcinoid Syndrome